open access

Vol 23, No 1 (2016)
Review Article
Published online: 2015-08-26
Get Citation

The use of anticoagulants in morbidly obese patients

Justyna Domienik-Karłowicz, Piotr Pruszczyk
DOI: 10.5603/CJ.a2015.0054
·
Pubmed: 26412600
·
Cardiol J 2016;23(1):12-16.

open access

Vol 23, No 1 (2016)
Review articles
Published online: 2015-08-26

Abstract

Due to its constantly growing incidence, obesity is an increasingly serious social and medical problem. Available data on the use of novel oral anticoagulants in morbidly obese and obese patients are very limited. However, we tried to summarize the available knowledge on the use of anticoagulants in this subpopulation of patients in everyday clinical practice. Studies on the clinical use of anticoagulants provide a poor basis for any adjustment of doses in obese patients as compared to patients with normal body weight. In our opinion, further studies are required in this particular population.

Abstract

Due to its constantly growing incidence, obesity is an increasingly serious social and medical problem. Available data on the use of novel oral anticoagulants in morbidly obese and obese patients are very limited. However, we tried to summarize the available knowledge on the use of anticoagulants in this subpopulation of patients in everyday clinical practice. Studies on the clinical use of anticoagulants provide a poor basis for any adjustment of doses in obese patients as compared to patients with normal body weight. In our opinion, further studies are required in this particular population.

Get Citation

Keywords

morbid obesity, obesity, bariatric surgery, anticoagulant drugs, factor Xa inhibitors, heparin

About this article
Title

The use of anticoagulants in morbidly obese patients

Journal

Cardiology Journal

Issue

Vol 23, No 1 (2016)

Article type

Review Article

Pages

12-16

Published online

2015-08-26

DOI

10.5603/CJ.a2015.0054

Pubmed

26412600

Bibliographic record

Cardiol J 2016;23(1):12-16.

Keywords

morbid obesity
obesity
bariatric surgery
anticoagulant drugs
factor Xa inhibitors
heparin

Authors

Justyna Domienik-Karłowicz
Piotr Pruszczyk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl